{
  "thread": {
    "uuid": "8d9cb4c1e732b7eb18f941a78e1943319343eb6e",
    "url": "https://finance.sina.com.cn/stock/aiassist/pzzd/2025-06-19/doc-infaqrft3925963.shtml",
    "site_full": "finance.sina.com.cn",
    "site": "sina.com.cn",
    "site_section": "https://finance.sina.cn",
    "site_categories": [
      "tech",
      "top_news_hk",
      "top_news_sg",
      "top_news_tw",
      "top_news"
    ],
    "section_title": "新浪财经_金融信息服务商",
    "site_title": null,
    "title": "艾力斯跌2.07%，成交额1.42亿元，主力资金净流入162.22万元_新浪财经_新浪网",
    "title_full": "艾力斯跌2.07%，成交额1.42亿元，主力资金净流入162.22万元_新浪财经_新浪网",
    "published": "2025-06-19T06:27:00.000+03:00",
    "replies_count": 0,
    "participants_count": 1,
    "site_type": "news",
    "country": "CN",
    "main_image": "",
    "performance_score": 0,
    "domain_rank": 236,
    "domain_rank_updated": "2025-06-03T00:00:00.000+03:00",
    "licensing_agency": [],
    "social": {
      "facebook": {
        "likes": 0,
        "comments": 0,
        "shares": 0
      },
      "vk": {
        "shares": 0
      }
    }
  },
  "uuid": "8d9cb4c1e732b7eb18f941a78e1943319343eb6e",
  "url": "https://finance.sina.com.cn/stock/aiassist/pzzd/2025-06-19/doc-infaqrft3925963.shtml",
  "ord_in_thread": 0,
  "author": "小浪财讯",
  "published": "2025-06-19T06:27:00.000+03:00",
  "title": "艾力斯跌2.07%，成交额1.42亿元，主力资金净流入162.22万元_新浪财经_新浪网",
  "text": "6月19日， 艾力斯 盘中下跌2.07%，截至11:27，报91.66元/股，成交1.42亿元，换手率0.34%，总市值412.47亿元。\n资金流向方面，主力资金净流入162.22万元，特大单买入262.39万元，占比1.85%，卖出352.32万元，占比2.48%；大单买入2599.68万元，占比18.33%，卖出2347.52万元，占比16.55%。\n艾力斯今年以来股价涨53.65%，近5个交易日跌4.53%，近20日涨4.25%，近60日涨17.09%。\n资料显示，上海艾力斯医药科技股份有限公司位于上海市浦东新区周浦镇凌霄花路268号，成立日期2004年3月22日，上市日期2020年12月2日，公司主营业务涉及创新药物的研发、生产和销售。主营业务收入构成为：抗肿瘤类产品的销售98.53%，技术授权及服务收入1.47%，其他业务0.00%。\n艾力斯所属申万行业为：医药生物-化学制药-化学制剂。所属概念板块包括：抗癌药物、抗癌治癌、创新药、生物医药、融资融券等。\n截至3月31日，艾力斯股东户数1.26万，较上期减少3.10%；人均流通股35825股，较上期增加3.20%。2025年1月-3月，艾力斯实现营业收入10.98亿元，同比增长47.86%；归母净利润4.10亿元，同比增长34.13%。\n分红方面，艾力斯A股上市后累计派现4.72亿元。\n机构持仓方面，截止2025年3月31日，艾力斯十大流通股东中，香港中央结算有限公司位居第五大流动股东，持股1283.87万股，相比上期减少17.39万股。华夏上证科创板50成份ETF（588000）位居第六大流动股东，持股1110.10万股，为新进股东。易方达上证科创板50ETF（588080）位居第九大流动股东，持股905.15万股，为新进股东。",
  "highlightText": "",
  "highlightTitle": "",
  "highlightThreadTitle": "",
  "language": "chinese",
  "sentiment": "negative",
  "categories": [
    "Economy, Business and Finance",
    "Social Issue",
    "Politics"
  ],
  "topics": [
    "Economy, Business and Finance->financial service",
    "Economy, Business and Finance->business reporting and performance",
    "Economy, Business and Finance->market and exchange",
    "Politics->economic policy",
    "Politics->regulation of industry",
    "Politics->government"
  ],
  "ai_allow": true,
  "has_canonical": false,
  "breaking": null,
  "webz_reporter": false,
  "external_links": [],
  "entities": {
    "persons": [],
    "locations": [],
    "organizations": []
  },
  "syndication": {
    "syndicated": null,
    "syndicate_id": null,
    "first_syndicated": false
  },
  "trust": {
    "categories": [],
    "top_news": [
      "top_news_hk",
      "top_news_sg",
      "top_news_tw",
      "top_news"
    ],
    "bias": null
  },
  "rating": null,
  "crawled": "2025-06-19T07:35:40.558+03:00",
  "updated": "2025-06-20T05:05:17.000+00:00"
}